Clinical Trials
3 trialsNCT02963610 2021-12-30
Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer
Fox Chase Cancer Center
Phase 1/2 Terminated
NCT02018523 2018-01-18
Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer
Baylor College of Medicine
Phase 1 Terminated
NCT01166035 2010-07-20
TEXO
Medical University Innsbruck
Phase 1/2 Unknown